Macrophage membrane coated persistent luminescence nanoparticle@MOF-derived mesoporous carbon core–shell nanocomposites for autofluorescence-free imaging-guided chemotherapy

Abstract

Efficient drug nanocarriers with high drug loading capacity and luminescent ability are in high demand for biomedical applications. Here we show a facile and bio-friendly synthesis of macrophage membrane coated persistent luminescence nanoparticle (PLNP)@metal–organic framework (MOF)-derived mesoporous carbon (MC) core–shell nanocomposites (PLMCs) for autofluorescence-free imaging-guided chemotherapy. MOF UiO-66 is used as both the precursor and the template, and is controllably coated on the surface of the PLNP to form a PLNP@UiO-66 core–shell composite. Subsequent calcination enables the transformation of PLNP@UiO-66 to PLMC due to the pyrolysis of the UiO-66 shell. PLMC with a small particle size of 70 nm, a tunable large pore size from ∼4.8 to ∼16.2 nm in the shell and near-infrared persistent luminescence in the core was prepared by controlling the calcination conditions. The prepared PLMC showed an enhanced drug loading capacity for three model drugs (doxycycline hydrochloride, acetylsalicylic acid, and paclitaxel) compared with PLNP@UiO-66. Further coating of the macrophage membrane on the surface of PLMC results in MPLMC with enhanced cloaking ability for evading the mononuclear phagocyte system. The drug-loaded MPLMC is promising for autofluorescence-free persistent luminescence imaging-guided drug delivery and tumor therapy.